The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for eFFECTOR Therapeutics, Inc. The notice, which signifies the SEC's approval of a previously filed registration statement, became effective on August 1, 2024. The document, bearing the accession number 0001193125-24-188836 and submission type POS AM, is associated with the company's file number 333-259751. This milestone is a regulatory step forward for eFFECTOR Therapeutics, indicating that the company has met the necessary SEC requirements to move ahead with its plans as outlined in the registration statement.

The United States Securities and Exchange Commission (SEC) has declared a notice of effectiveness for eFFECTOR Therapeutics, Inc. The notice, which signifies the SEC's approval of a previously filed registration statement, became effective on August 1, 2024. The document, bearing the accession number 0001193125-24-188836 and submission type POS AM, is associated with the company's file number 333-259751. This milestone is a regulatory step forward for eFFECTOR Therapeutics, indicating that the company has met the necessary SEC requirements to move ahead with its plans as outlined in the registration statement.